Cell sources for cardiovascular tissue engineering;Zellquellen für kardio-vaskuläres Tissue Engineering

Chirurg

Volumn 82, Issue 4, 2011, Pages 295-302

  Klopsch, C ^a   Donndorf, P ^a   Kaminski, A ^a   Ma, N ^a   Steinhoff, G ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Heart valves; Multipotent; Myocardium; Pluripotent; Stem cells

Indexed keywords

ANIMAL; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CYTOLOGY; EMBRYONIC STEM CELL; ETHICS; HUMAN; MEDICAL ETHICS; METHODOLOGY; MULTIPOTENT STEM CELL; PHYSIOLOGY; PLURIPOTENT STEM CELL; RESEARCH ETHICS; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION; TOTIPOTENT STEM CELL; TRANSPLANTATION;

ANIMALS; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; ETHICS, MEDICAL; ETHICS, RESEARCH; GUIDED TISSUE REGENERATION; HUMANS; MULTIPOTENT STEM CELLS; PLURIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TOTIPOTENT STEM CELLS;

EID: 79953308822     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-010-2030-3     Document Type: Article

References (112)

1. Garry DJ, Olson EN (2006) A common progenitor at the heart of development. Cell 127: 1101-1104.
2. Schneider VA, Mercola M (2001) Wnt antagonism initiates cardiogenesis in Xenopus laevis. Genes Dev 15: 304-315.
3. Shi Y, Katsev S, Cai C, Evans S (2000) BMP signaling is required for heart formation in vertebrates. Dev Biol 224: 226-237.
4. Kelly RG, Brown NA, Buckingham ME (2001) The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev Cell 1: 435-440.
5. Cai CL, Liang X, Shi Y et al (2003) Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 5: 877-889.
6. Peterkin T, Gibson A, Loose M, Patient R (2005) The roles of GATA-4, -5 and -6 in vertebrate heart development. Semin Cell Dev Biol 16: 83-94.
7. Brown DD, Martz SN, Binder O et al (2005) Tbx5 and Tbx20 act synergistically to control vertebrate heart morphogenesis. Development 132: 553-563.
8. Buckingham M, Meilhac S, Zaffran S (2005) Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 6: 826-835.
9. Laugwitz KL, Moretti A, Lam J et al (2005) Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433: 647-653.
10. Moretti A, Caron L, Nakano A et al (2006) Multipotent embryonic isl1+ Progenietor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127: 1151-1165.
11. Sun Y, Liang X, Najafi N et al (2007) Islet 1 is expressed in distinct cardiovascular lineages, including pacemaker and coronary vascular cells. Dev Biol 304: 286-296.
12. Kehat I, Kenyagin-Karsenti D, Snir M et al (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108: 407-414.
13. Pillekamp F, Reppel M, Rubenchyk O et al (2007) Force measurements of human embryonic stem cell-derived cardiomyocytes in an in vitro transplantation model. Stem Cells 25: 174-180.
14. Laflamme MA, Chen KY, Naumova AV et al (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25: 1015-1024.
15. Robey TE, Saiget MK, Reinecke H, Murry CE (2008) Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 45: 567-581.
16. Assmus B, Honold J, Schächinger V et al (2006) Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355: 1222-1232.
17. Leor J, Cohen S (2004) Myocardial tissue engineering: creating a muscle patch for a wounded heart. Ann N Y Acad Sci 1015: 312-319.
18. Kofidis T, Bruin JL de, Hoyt G et al (2005) Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. J Heart Lung Transplant 24: 737-744.
19. Nussbaum J, Minami E, Laflamme MA et al (2007) Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 21: 1345-1357.
20. Barberi T, Bradbury M, Dincer Z et al (2007) Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med 13: 642-648.
21. Knoepfler PS (2009) Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 27: 1050-1056.
22. De Coppi P, Bartsch G Jr, Siddiqui MM et al (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25: 100-106.
23. Zhang X, Stojkovic P, Przyborski S et al (2006) Derivation of human embryonic stem cells from developing and arrested embryos. Stem Cells 24: 2669-2676.
24. French AJ, Adams CA, Anderson LS et al (2008) Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells 26: 485-493.
25. Meissner A, Jaenisch R (2006) Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts. Nature 439: 212-215.
26. St John J, Lovell-Badge R (2007) Human-animal cytoplasmic hybrid embryos, mitochondria, and an energetic debate. Nat Cell Biol 9: 988-992.
27. Mai Q, Yu Y, Li T et al (2007) Derivation of human embryonic stem cell lines from parthenogenetic blastocysts. Cell Res 17: 1008-1019.
28. Kim K, Lerou P, Yabuuchi A et al (2007) Histocompatible embryonic stem cells by parthenogenesis. Science 315: 482-486.
29. Guan K, Nayernia K, Maier LS et al (2006) Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 440: 1199-1203.
30. Guan K, Wagner S, Unsöld B et al (2007) Generation of functional cardiomyocytes from adult mouse spermatogonial stem cells. Circ Res 100: 1615-1625.
31. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
32. Nakagawa M, Koyanagi M, Tanabe K et al (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26: 101-106.
33. Maherali N, Sridharan R, Xie W et al (2007) Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1: 55-70.
34. Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317.
35. Wernig M, Meissner A, Foreman R et al (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318-324.
36. Mauritz C, Schwanke K, Reppel M et al (2008) Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118: 507-517.
37. Wilson KD, Venkatasubrahmanyam S, Jia F et al (2009) MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev 18: 749-758.
38. Chen S, Takanashi S, Zhang Q et al (2007) Reversine increases the plasticity of lineage-committed mammalian cells. Proc Natl Acad Sci U S A 104: 10482-10487.
39. Kadner A, Zund G, Maurus C et al (2004) Human umbilical cord cells for cardiovascular tissue engineering: a comparative study. Eur J Cardiothorac Surg 25: 635-641.
40. Furfaro EM, Gaballa MA (2007) Do adult stem cells ameliorate the damaged myocardium? Human cord blood as a potential source of stem cells. Curr Vasc Pharmacol 5: 27-44.
41. Henning RJ, Abu-Ali H, Balis JU et al (2004) Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant 13: 729-739.
42. Ma N, Ladilov Y, Moebius JM et al (2006) Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells. Cardiovasc Res 71: 158-169.
43. Gaebel R, Furlani D, Sorg H et al (2011) CD105 expression on human mesenchymal stemcells depends on cell origin and determines a different healing performance in cardiac regeneration. PLoS One (in press).
44. Yerebakan C, Sandica E, Prietz S et al (2009) Autologous umbilical cord blood mononuclear cell transplantation preserves right ventricular function in a novel model of chronic right ventricular volume overload. Cell Transplant 18: 855-868.
45. Steinhoff G (2006) The regenerating heart - hope for children with congenital heart defects. Kinderkrankenschwester 25: 47-50.
46. Lin G, Garcia M, Ning H et al (2008) Defining stem and progenitor cells within adipose tissue. Stem Cells Dev 17: 1053-1063.
47. Lin CS, Xin ZC, Deng CH et al (2010) Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol 25: 807-815.
48. Schäffler A, Büchler C (2007) Concise review: adipose tissue-derived stromal cells - basic and clinical implications for novel cell-based therapies. Stem Cells 25: 818-827.
49. Rangappa S, Fen C, Lee EH et al (2003) Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg 75: 775-779.
50. Planat-Benard V, Silvestre JS, Cousin B et al (2004) Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109: 656-663.
51. Suga H, Eto H, Aoi N et al (2010) Adipose tissue remodeling under ischemia: death of adipocytes and activation of stem/progenitor cells. Plast Reconstr Surg 126: 1911-1923.
52. Oh JS, Kim KN, An SS et al (2010) Co-transplantation of Mouse Neural Stem Sells (mNSCs) with Adipose Tissue-derived Mesenchymal Stem Sells Improves mNSC Survival in a Rat Spinal Cord Injury Model. Cell Transplant. DOI: 10. 3727/096368910X539083.
53. Orlic D, Kajstura J, Chimenti S et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705.
54. Kalka C, Masuda H, Takahashi T et al (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97: 3422-3427.
55. Stamm C, Westphal B, Kleine HD et al (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361: 45-46.
56. Werner N, Wassmann S, Ahlers P et al (2007) Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 102: 565-571.
57. Hill JM, Zalos G, Halcox JP et al (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600.
58. Werner N, Kosiol S, Schiegl T et al (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007.
59. Yerebakan C, Kaminski A, Liebold A, Steinhoff G (2007) Safety of intramyocardial stem cell therapy for the ischemic myocardium: results of the Rostock trial after 5-year follow-up. Cell Transplant 16: 935-940.
60. Abdel-Latif A, Bolli R, Tleyjeh IM et al (2007) Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167: 989-997.
61. Schächinger V, Erbs S, Elsässer A et al (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355: 1210-1221.
62. Stamm C, Kleine HD, Choi YH et al (2007) Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 133: 717-725.
63. Kajstura J, Rota M, Whang B et al (2005) Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 96: 127-137.
64. Murry CE, Soonpaa MH, Reinecke H et al (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428: 664-668.
65. Chien KR (2006) Lost and found: cardiac stem cell therapy revisited. J Clin Invest 116: 1838-1840.
66. Klopsch C, Furlani D, Gaebel R et al (2009) Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J Cell Mol Med 13: 664-679.
67. Stein A, Knodler M, Makowski M et al (2010) Local erythropoietin and endothelial progenitor cells improve regional cardiac function in acute myocardial infarction. BMC Cardiovasc Disord 10: 43.
68. Ward MR, Stewart DJ (2008) Erythropoietin and mesenchymal stromal cells in angiogenesis and myocardial regeneration: one plus one equals three? Cardiovasc Res 79: 357-359.
69. Wang W, Li W, Ong LL et al (2010) Localized SDF-1alpha gene release mediated by collagen substrate induces CD117 stem cells homing. J Cell Mol Med 14: 392-402.
70. Wang W, Li W, Ou L et al (2010) Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients. J Cell Mol Med. DOI: 10. 1111/j. 1582-4934. 2010. 01130. x.
71. Kern S, Eichler H, Stoeve J et al (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301.
72. Leri A, Kajstura J, Anversa P (2005) Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 85: 1373-1416.
73. Oswald J, Boxberger S, Jørgensen B et al (2004) Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22: 377-384.
74. Rangappa S, Entwistle JW, Wechsler AS, Kresh JY (2003) Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. J Thorac Cardiovasc Surg 126: 124-132.
75. Hakuno D, Fukuda K, Makino S et al (2002) Bone marrow-derived regenerated cardiomyocytes (CMG cells) express functional adrenergic and muscarinic receptors. Circulation 105: 380-386.
76. Zhang FB, Li L, Fang B et al (2005) Passage-restricted differentiation potential of mesenchymal stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun 336: 784-792.
77. Rosca AM, Burlacu A (2010) The effect of 5-azacytidine: evidence for alteration of the multipotent ability of mesenchymal stem cells. Stem Cells Dev. DOI: 10. 1089/scd. 2010. 0433.
78. Huang XP, Sun Z, Miyagi Y et al (2010) Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 122: 2419-2429.
79. Furlani D, Ugurlucan M, Ong L et al (2009) Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc Res 77: 370-376.
80. Plotnikov AN, Shlapakova I, Szabolcs MJ et al (2007) Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation 116: 706-713.
81. Yang XJ, Zhou YF, Li HX et al (2008) Mesenchymal stem cells as a gene delivery system to create biological pacemaker cells in vitro. J Int Med Res 36: 1049-1055.
82. Menasché P (2007) Skeletal myoblasts as a therapeutic agent. Prog Cardiovasc Dis 50: 7-17.
83. Taylor DA, Atkins BZ, Hungspreugs P et al (1998) Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4: 929-933.
84. Pouly J, Hagège AA, Vilquin JT et al (2004) Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy? Circulation 110: 1626-1631.
85. Choi YH, Stamm C, Hammer PE et al (2006) Cardiac conduction through engineered tissue. Am J Pathol 169: 72-85.
86. Anversa P, Kajstura J, Leri A, Bolli R (2006) Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 113: 1451-1463.
87. Bergmann O, Bhardwaj RD, Bernard S et al (2009) Evidence for cardiomyocyte renewal in humans. Science 324: 98-102.
88. Beltrami AP, Barlucchi L, Torella D et al (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776.
89. Bearzi C, Rota M, Hosoda T et al (2007) Human cardiac stem cells. Proc Natl Acad Sci U S A 104: 14068-14073.
90. Gäbel R, Klopsch C, Furlani D et al (2009) Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats. Interact Cardiovasc Thorac Surg 9: 20-25.
91. Rossini A, Zacheo A, Mocini D et al (2008) HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. J Mol Cell Cardiol 44: 683-693.
92. Madonna R, Shelat H, Xue Q et al (2009) Erythropoietin protects myocardin-expressing cardiac stem cells against cytotoxicity of tumor necrosis factor-alpha. Exp Cell Res 315: 2921-2928.
93. Kaminski A, Ma N, Donndorf P et al (2008) Endothelial NOS is required for SDF-1alpha/CXCR4-mediated peripheral endothelial adhesion of c-kit+ bone marrow stem cells. Lab Invest 88: 58-69.
94. Steinhoff G, Stock U, Karim N et al (2000) Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 102: III50-III55.
95. Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ (2004) Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J Heart Valve Dis 13: 841-847.
96. Merryman WD, Liao J, Parekh A et al (2007) Differences in tissue-remodeling potential of aortic and pulmonary heart valve interstitial cells. Tissue Eng 13: 2281-2289.
97. Simon A, Wilhelmi M, Steinhoff G et al (1998) Cardiac valve endothelial cells: relevance in the long-term function of biologic valve prostheses. J Thorac Cardiovasc Surg 116: 609-616.
98. Stamm C, Khosravi A, Grabow N et al (2004) Biomatrix/polymer composite material for heart valve tissue engineering. Ann Thorac Surg 78: 2084-2092.
99. Grabow N, Schmohl K, Khosravi A et al (2004) Mechanical and structural properties of a novel hybrid heart valve scaffold for tissue engineering. Artif Organs 28: 971-979.
100. Bader A, Steinhoff G, Strobl K et al (2000) Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation 70: 7-14.
101. Zimmermann WH, Melnychenko I, Wasmeier G et al (2006) Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12: 452-458.
102. Matsubayashi K, Fedak PW, Mickle DA et al (2003) Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation 108: II219-II225.
103. Bader A, Schilling T, Teebken OE et al (1998) Tissue engineering of heart valves - human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg 14: 279-284.
104. Tan MY, Zhi W, Wei RQ et al (2009) Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 30: 3234-3240.
105. Lutter G, Metzner A, Jahnke T et al (2010) Percutaneous tissue-engineered pulmonary valved stent implantation. Ann Thorac Surg 89: 259-263.
106. Herring M, Gardner A, Glover J (1979) Seeding endothelium onto canine arterial prostheses. The effects of graft design. Arch Surg 114: 679-682.
107. Graham LM, Burkel WE, Ford JW et al (1982) Expanded polytetrafluoroethylene vascular prostheses seeded with enzymatically derived and cultured canine endothelial cells. Surgery 91: 550-559.
108. Riha GM, Lin PH, Lumsden AB et al (2005) Review: application of stem cells for vascular tissue engineering. Tissue Eng 11: 1535-1552.
109. Flanagan TC, Sachweh JS, Frese J et al (2009) In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng Part A 15: 2965-2976.
110. Kaminski A, Klopsch C, Mark P et al (2010) Autologous valve replacement - CD133+ stem cell-plus-fibrin composite based sprayed cell seeding for intra-operative heart valve tissue engineering, Tissue Eng C. DOI: 10. 1089/ten. tec. 2010. 0051.
111. Yildirim Y, Naito H, Didié M et al (2007) Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation 116: I16-23.
112. Zimmermann WH, Eschenhagen T (2007) Embryonic stem cells for cardiac muscle engineering. Trends Cardiovasc Med 17: 134-140.